Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze TSHA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TSHA investment potential.

What is TSHA stock price today?

Get real-time TSHA stock price, historical data, and price charts on Financhill. Track TSHA performance with our advanced analysis tools.

Is TSHA a good investment?

Evaluate TSHA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TSHA stock?

To buy TSHA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TSHA?

View detailed market capitalization data and company valuation metrics for TSHA on our comprehensive analysis page.

What is the P/E ratio of TSHA?

Use our fundamental analysis tools to view TSHA P/E ratio and compare valuation metrics with industry peers.

What are TSHA earnings?

View TSHA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Taysha Gene Therapies, Inc. 10K Form

Buy

TSHA
Taysha Gene Therapies, Inc.

Last Price:

$5.05

Seasonality Move:

-10.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TSHA News And Ratings

See the #1 stock for the next 7 days that we like better than TSHA

TSHA Financial Statistics

Sales & Book Value

Annual Sales:	$8.3M
Cash Flow:	$-24.3M
Price / Cash Flow:	0
Annual Sales:	$0.80
Price / Book:	6.32

Profitability

EPS (TTM):	-0.35440
Net Income (TTM):	$-99.9M
Gross Margin:	$7.1M
Return on Equity:	-73.14%
Return on Assets:	-40.14%

Taysha Gene Therapies, Inc. Earnings Forecast

Key Taysha Gene Therapies, Inc. Financial Ratios

The Gross Profit Margin over the past 4 years for TSHA is 85.06%.
The Selling, General & Administrative Expenses for TSHA have been equal to 347.45% of Gross Profit Margin.
The Research & Development expenses have been 792.04% of Revenue.
The Net Earning history of TSHA is -1,071.62% of Total Revenues.
Per Share Earnings over the last 5 years have been positive in 3 years.

Taysha Gene Therapies, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	TSHA
CUSIP:	877619
Website:	tayshagtx.com

Debt

Debt-to-Equity Ratio:	0.32
Current Ratio:	10.47
Quick Ratio:	10.4

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

TSHA Technical Analysis vs Fundamental Analysis

Buy

Taysha Gene Therapies, Inc. (TSHA) is a Buy

Is Taysha Gene Therapies, Inc. a Buy or a Sell?

Taysha Gene Therapies, Inc. stock is rated a Buy

The current Taysha Gene Therapies, Inc. [TSHA] share price is $5.05. The Score for TSHA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.